Page last updated: 2024-12-06

asparkam

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Asparkam is a potassium chloride supplement used to treat low potassium levels in the body. It is often prescribed for people with conditions that cause potassium loss, such as diuretic use, severe vomiting, or diarrhea. Asparkam is not synthesized, but rather is a naturally occurring compound. Potassium is an essential mineral that plays a role in many important bodily functions, including nerve impulses, muscle contractions, and heart rhythm. When potassium levels are low, it can lead to a variety of symptoms such as muscle weakness, fatigue, and irregular heartbeat. Asparkam is studied to understand its efficacy in treating low potassium levels and to determine the optimal dosage and route of administration. It is considered safe and effective when used as directed. However, it can interact with certain medications, and it is important to consult with a healthcare provider before taking Asparkam.'

Asparkam: Asparkam tablets contain potassium & magnesium aspartate [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71375
MeSH IDM0083102

Synonyms (13)

Synonym
l-aspartic acid, monopotassium salt, mixt. with dihydrogen (t-4)-bis(l-aspartato(2-)-kappan,kappao1)magnesate(2-)
potassium aspartate and magnesium aspartate [usan:jan]
wy 2837
potassium aspartate and magnesium aspartate
magnesium potassium l-aspartate
asparkam
wy 2838
l-aspartic acid, monopotassium salt, mixt. with dihydrogen (t-4)-bis(l-aspartato(2-)-n,o(sup 1)magnesate(2-)
l-aspartic acid, monopotassium salt, mixt. with dihydrogen (t-4)-bis(l-aspartato(2-)-n,o1)magnesate(2-)
14842-81-0
unii-55tui7q42i
magnesate(2-), bis(laspartato(2-)-kappan,kappao1)-, (t-4)-, dihydrogen, mixt. contg.
magnesium;potassium;(2s)-2-amino-4-hydroxy-4-oxobutanoate;2-amino-4-hydroxy-4-oxobutanoate
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 51.45

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index51.45 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.18 (4.65)
Search Engine Demand Index76.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (51.45)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]